Healthcare Services

Metabolomics Market Revenue Growth Expected to Reach $9.28 Billion by 2030 with 17.3% CAGR

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Metabolomics Market Between 2026 And 2030?

The metabolomics market has experienced rapid expansion recently. It is projected to increase from $4.17 billion in 2025 to $4.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.5%. The expansion witnessed in the past can be attributed to heightened biomarker discovery research, increasing adoption of mass spectrometry, a surge in cancer metabolism studies, the broadening use of chromatography systems, and advancements in metabolite profiling techniques.

The metabolomics market is projected for significant expansion in the coming years. By 2030, its value is anticipated to reach $9.29 billion, expanding at a compound annual growth rate (CAGR) of 17.3%. This projected increase during the forecast period stems from factors such as advancements in bioinformatics tools, a heightened emphasis on personalized medicine, a growing need for nutrigenomics applications, increased research into metabolic pathways, and the broader integration into clinical diagnostics. Key trends anticipated over this period encompass the convergence of precision medicine with metabolomic profiling, the proliferation of cloud-based metabolomics data platforms, AI-powered metabolite pattern recognition, enhanced automation in high-throughput metabolomics workflows, and IoT-enabled real-time metabolic monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

What Key Drivers Are Influencing The Growth Of The Metabolomics Market?

The increasing incidence of cancer is anticipated to drive the expansion of the metabolomics market. Cancer is defined as a collection of illnesses where abnormal cells proliferate uncontrollably, invade tissues, and have the potential to spread to other areas of the body. The growing prevalence of cancer is attributed to an aging population, as advanced age serves as the most significant risk factor for developing most cancer types, with the majority of diagnoses occurring in individuals over 65 years old. Metabolomics supports cancer research by offering a comprehensive overview of metabolic alterations in tumor cells, which facilitates early detection, understanding of disease mechanisms, and identification of potential therapeutic targets. For instance, in February 2024, according to the World Health Organization, a Switzerland-based international organization specializing in global health policy and public health initiatives, over 35 million new cancer cases are predicted in 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the rising prevalence of cancers is propelling the growth of the metabolomics market.

Which Market Segments Are Examined In The Metabolomics Market Study?

The metabolomics market covered in this report is segmented –

1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services

2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications

3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications

Subsegments:

1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance)

2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services

What Key Trends Are Influencing The Development Of The Metabolomics Market?

Leading companies within the metabolomics market are prioritizing the implementation of Integrated Bioinformatics Platforms to enhance the understanding of complex metabolomic data, consequently fostering progress in personalized medicine, the identification of biomarkers, and insights into diseases. An Integrated Bioinformatics Platform is a comprehensive software solution that brings together various bioinformatics tools and databases to simplify the analysis and interpretation of biological information. Researchers can align metabolomics data with Metabolon’s accurate biochemical pathway maps, which aids in revealing biological processes and disease mechanisms. For example, in February 2024, Metabolon, Inc., a US-based firm, introduced its bioinformatics platform. The Biomarker Lenses feature within the Integrated Bioinformatics Platform empowers users to apply advanced analytical filters to concentrate on metabolites connected to specific pathways or diseases, promoting a more targeted examination of metabolomic data. Furthermore, the platform offers tools for conducting statistical analyses such as T-tests and ANOVAs, enabling researchers to develop and compare statistical models, manage metadata, and visualize outcomes effectively.

Who Are The Primary Competitors In The Metabolomics Market?

Major companies operating in the metabolomics market are Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.

Read the full metabolomics market report here:

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Metabolomics Market?

North America was the largest region in the metabolomics market in 2025. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Metabolomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2497&type=smp

Browse Through More Reports Similar to the Global Metabolomics Market 2026, By The Business Research Company

Biochemistry Analyzer Global Market Report

https://www.thebusinessresearchcompany.com/report/biochemistry-analyzer-global-market-report

Metabolomics Global Market Report

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Point Of Care Glucose Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795